PHARMACORP RX launches C$10M bought-deal offering
Seeking Alpha ·
PHARMACORP RX ( PCRX:CA ) has entered into a bought-deal agreement to issue 19.6M units at C$0.51 each, raising gross proceeds of C$10M. Acumen Capital Finance Partners and Canaccord Genuity are co-leading the underwriting syndicate. Each unit includes one common share and one-half
DYAX Investor Sentiment
Bullish (Long) 59% · Bearish (Short) 41%
269 participants
Related News
- XWELL agrees to divest XpresSpa, XpresTest units for $13M
- Accenture launches Accenture Edge with Google Cloud to deliver agentic AI solutions for mid-market companies
- CuriosityStream takes full ownership of German operations
- Saipem awarded $2B contract for Indonesia offshore gas project
- DigitalOcean surges after forecasting record Q2 results, RPO, new data center capacity
- Google Backs Fusion Startup Proxima